BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS






Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





 Company News
GlobeImmune, Inc. (GBIM) Announces Opening Of Randomized Phase 2 Chordoma Trial At National Cancer Institute 4/22/2015 10:42:17 AM
New Blood Test Shows Promise In Cancer Fight, National Cancer Institute Study 4/21/2015 6:52:53 AM
Kite Pharma (KITE) Announces Publication In Science Of Cancer Immunotherapy Articles Authored By Lead Collaborators At The National Cancer Institute And The Netherlands Cancer Institute (NCI) 4/6/2015 7:01:21 AM
Intrexon Corporation Signs Cooperative Research And Development Agreement (CRADA) With The National Cancer Institute For RheoSwitch Controlled IL-12 Cancer Therapies Using T Cell Receptors (TCR) Derived From Peripheral Blood 4/2/2015 6:50:56 AM
ABL Awarded National Cancer Institute Contract To Continue Groundbreaking Retroviral Research 3/24/2015 10:50:50 AM
WMIS To Collaborate With National Cancer Institute Of The NIH To Focus On Expansion Of Co-Clinical Trials 3/11/2015 6:48:55 AM
Varmus Stepping Down As Director Of NIH’s National Cancer Institute 3/5/2015 6:35:00 AM
Kite Pharma (KITE) Expands Its Research And Development Collaboration With The National Cancer Institute To Develop A Next Generation Of Cancer Immunotherapy Products For Solid Tumors 3/2/2015 7:54:08 AM
National Cancer Institute Release: Raising Awareness About Cancer Clinical Trials In Multicultural Communities 2/19/2015 9:15:40 AM
UT Southwestern Medical Center Receives Key National Cancer Institute Funding To Plan First U.S. Center For Heavy Ion Radiation Therapy Research 2/11/2015 11:10:25 AM
12345678910...